Genentech Inc.: The South San Francisco-based biotechnology...
From Times Staff and Wire Reports
Genentech Inc.: The South San Francisco-based biotechnology firm said its first-quarter profit surged 46% to $19.4 million on revenue that jumped 10% to $132 million. The company said a 26% surge in sales of its Protropin growth hormone helped boost results.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
